The transcription factor c-Myc amplifies the transcription of many growth-related genes in cancer cells, but its role as an oncogene is not fully understood.

Biological variability has confounded efforts to confirm the role of PREX2 mutations in melanoma.

Experimental efforts to validate the output of a computational model that predicts new uses for existing drugs highlights the inherently complex nature of cancer biology.

Scientific abstracts have become less readable over the past 130 years, in part because recent texts include more general scientific jargon than older texts.

The association between the bacterium Fusobacterium nucleatum and human colon cancer is more complicated than it first appeared.

The first results from the Reproducibility Project: Cancer Biology suggest that there is scope for improving reproducibility in pre-clinical cancer research.

Targeting the transcription factor c-Myc via one of its coactivator proteins is a promising strategy for cancer therapy.

Editors' Summary: This Replication Study has reproduced important parts of the original paper.

Editors' Summary: This Replication Study has reproduced important parts of the original paper.